Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel anti-HIV agents reported in recent patent literature

Oct. 18, 2005

KP-1461 begins phase Ib study for HIV

Oct. 18, 2005

Updated HIV/AIDS treatment guidelines support Fuzeon + PI use

Oct. 17, 2005

VRC begins phase II testing of HIV vaccine developed with GenVec

Oct. 17, 2005

VIRxSYS completes financing

Oct. 14, 2005

Novel therapeutic agents for HIV infection disclosed

Oct. 11, 2005

GenVec and Vaccine Research Center HIV research program boosted by investment

Oct. 10, 2005

FDA request further phase II study for Reverset prior to phase III

Sep. 30, 2005

New anti-HIV agents described in recent patents

Sep. 27, 2005

Tripep advances alpha-HGA to phase I/II trial for HIV

Sep. 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...